Opinion: New beds fill gaps, won’t fix health-care woes - Winnipeg Free Press

Film and panel highlight need for communication and collaboration in interprofessional care. Over 360 health care and social work students attended a screening of the film Falling Through the Cracks: Greg’s Story on Oct. 5.  The moving 30-minute film was made in 2017 and follows the true story of Greg Price, an Alberta man who died at the age of 32 from an undiagnosed blood clot as a complication from testicular cancer. The Price family has held screenings at UM annually in the fall term for the past few years, either with panel discussions or students discussing the film in breakout groups. Hosted by the Office of Interprofessional Collaboration at the Rady Faculty of Health Sciences, the film was screened at the Frederic Gaspard Theatre on Bannatyne campus, as well as online for nursing students at Fort Garry campus and at the University College of the North (UCN) in The Pas and Thompson.  In total, 134 medical students attended, along with 124 nursing students (UM and UCN), 61 pharmacy students, 40 respiratory therapy students and 10 students from the Faculty of Social Work.

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.